Xinguang Yu Selected Research

Therapeutics

3/2020	Repetitive transcranial magnetic stimulation for cognitive impairment in Alzheimer's disease: a meta-analysis of randomized controlled trials.
1/2020	Necroptotic astrocytes contribute to maintaining stemness of disseminated medulloblastoma through CCL2 secretion.
11/2019	Deep brain stimulation for Meige syndrome: a meta-analysis with individual patient data.
10/2019	Image-based analysis and long-term clinical outcomes of deep brain stimulation for Tourette syndrome: a multisite study.
1/2019	Therapeutic Effect of Hypofractionated Stereotactic Radiotherapy Using CyberKnife for High Volume Cavernous Sinus Cavernous Hemangiomas.
4/2018	Imaging of Sodium MRI for Therapy Evaluation of Brain Metastase with Cyberknife at 7T: A Case Report.
3/2015	[Endoscopic treatment strategy of obstructive hydrocephalus induced by pineal region tumors].
3/2015	[Treatment for giant pituitary adenomas through transcranial approach in a series of 112 consecutive patients].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xinguang Yu Research Topics

Disease

17	Neoplasms (Cancer) 01/2021 - 08/2014
10	Glioma (Gliomas) 01/2021 - 01/2015
5	Hydrocephalus (Hydrocephaly) 11/2015 - 03/2015
4	Pituitary ACTH Hypersecretion 01/2022 - 01/2021
4	Glioblastoma (Glioblastoma Multiforme) 10/2020 - 04/2015
3	Cognitive Dysfunction 01/2021 - 03/2020
3	Hematoma 11/2018 - 08/2014
3	Brain Ischemia (Cerebral Ischemia) 01/2018 - 12/2014
3	Infarction (Infarctions) 04/2015 - 12/2014
2	Epilepsy (Aura) 01/2022 - 08/2018
2	Dystonia (Limb Dystonia) 02/2021 - 11/2019
2	Tuberous Sclerosis (Bourneville's Disease) 01/2021 - 08/2018
2	Inflammation (Inflammations) 01/2021 - 10/2017
2	Seizures (Absence Seizure) 10/2020 - 12/2014
2	Neoplasm Metastasis (Metastasis) 01/2020 - 04/2015
2	Meige Syndrome 11/2019 - 04/2019
2	Brain Neoplasms (Brain Tumor) 01/2019 - 04/2018
2	Cerebral Hemorrhage 01/2019 - 01/2014
2	Parkinson Disease (Parkinson's Disease) 01/2019 - 01/2016
2	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 10/2018 - 01/2018
2	Intracranial Vasospasm 10/2018 - 01/2018
2	Pinealoma (Pineoblastoma) 03/2015 - 08/2014
2	Diabetes Insipidus 03/2015 - 12/2014
2	Stroke (Strokes) 12/2014 - 01/2014
2	Brain Abscess (Abscess, Brain) 07/2014 - 01/2014
1	Meningioma (Meningiomas) 03/2022
1	Brain Diseases (Brain Disorder) 01/2022
1	Myoclonus (Nocturnal Myoclonus) 02/2021
1	Myoclonic dystonia 02/2021
1	Hemangiopericytoma 01/2021
1	Alzheimer Disease (Alzheimer's Disease) 03/2020
1	Torticollis (Wryneck) 01/2020
1	Blepharospasm 11/2019
1	Tics (Tic) 10/2019
1	Tourette Syndrome (Tourette's Syndrome) 10/2019
1	Spinal Fractures 02/2019
1	Hypesthesia (Numbness) 01/2019
1	Diplopia (Double Vision) 01/2019
1	Temporal Lobe Epilepsy 01/2019
1	Brain Edema (Cerebral Edema) 01/2019
1	Headache (Headaches) 01/2019
1	Cavernous Hemangioma (Cavernous Angioma) 01/2019
1	Hippocampal Sclerosis 01/2019
1	Chronic Subdural Hematoma 11/2018
1	Necrosis 04/2018
1	Pain (Aches) 04/2018
1	Hearing Loss (Hearing Impairment) 01/2018

Drug/Important Bio-Agent (IBA)

10	Biomarkers (Surrogate Marker)IBA 01/2021 - 07/2015
6	Proteins (Proteins, Gene)FDA Link 03/2022 - 12/2014
4	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2022 - 01/2021
3	SodiumIBA 04/2018 - 12/2014
2	AmidesIBA 03/2022 - 10/2020
2	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2020
2	trans-sodium crocetinate (crocetin)IBA 01/2021 - 08/2018
2	Therapeutic UsesIBA 01/2021 - 01/2019
2	DNA (Deoxyribonucleic Acid)IBA 03/2020 - 06/2015
2	Long Noncoding RNAIBA 01/2019 - 07/2015
2	ElectrolytesIBA 03/2015 - 12/2014
1	Hemeproteins (Heme Protein)IBA 03/2022
1	Carotenoids (Carotene)IBA 03/2022
1	Fatty Acids (Saturated Fatty Acids)IBA 03/2022
1	GlucocorticoidsIBA 01/2022
1	2- benzylidene- 3- (cyclohexylamino)- 2,3- dihydro- 1H- inden- 1- oneIBA 01/2022
1	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2021
1	SuspensionsIBA 01/2021
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2021
1	A 7 (A-7)IBA 01/2021
1	Apolipoproteins E (ApoE)IBA 01/2021
1	ApolipoproteinsIBA 01/2021
1	InterleukinsIBA 01/2021
1	IronIBA 01/2021
1	InflammasomesIBA 01/2021
1	Indicators and Reagents (Reagents)IBA 10/2020
1	Genetic Markers (Genetic Marker)IBA 10/2020
1	Circulating Tumor DNAIBA 03/2020
1	LigandsIBA 01/2020
1	Biological ProductsIBA 01/2020
1	CC ChemokinesIBA 01/2020
1	Pharmaceutical PreparationsIBA 01/2020
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2019
1	Mannitol (Osmitrol)FDA LinkGeneric 01/2019
1	Atorvastatin (Lipitor)FDA Link 11/2018
1	astragaloside AIBA 10/2018
1	Hematoxylin (Haematoxylon)IBA 10/2018
1	Eosine Yellowish-(YS) (Eosin)IBA 10/2018
1	cardamoninIBA 01/2018
1	Galactosylceramides (Galactocerebrosides)IBA 12/2017

Therapy/Procedure

8	Deep Brain Stimulation 02/2021 - 01/2016
8	Therapeutics 03/2020 - 03/2015
6	Radiotherapy 01/2021 - 08/2014
3	Ventriculostomy 11/2015 - 08/2014
3	Drug Therapy (Chemotherapy) 04/2015 - 08/2014
2	Aftercare (After-Treatment) 01/2021 - 01/2018
2	Decompression 02/2019 - 04/2018
2	Immunotherapy 01/2018 - 12/2017
2	Ventriculoperitoneal Shunt 11/2015 - 10/2015
2	Catheters 11/2015 - 08/2015
2	Transplantation 04/2015 - 12/2014
2	Craniotomy 03/2015 - 08/2014
1	Transcranial Magnetic Stimulation 03/2020